Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) is a rare autosomal recessive disorder which is caused by a mutation in a gene DARS1.[1] HBSL usually begins at the age of 3-36 months, and the main signs of this disorder are: Regression of the motor milestones, epilepsy, intellectual disability, ataxia, nystagmus, and spasticity.[2][3]
Approximately 19 cases had been reported as of 2023.[4]
Abnormalities of the dorsal columns of the spinal cord
Cause
HBSL is caused by a mutation in a gene DARS1, which encodes protein aspartyl-tRNA synthetase, cytoplasmic.[7]
Pathophysiology
According to studies, the hypomorphic variant of DARS1 causes decreased levels of the myelin proteins (such as PLP1, MBP, and CNP), which might be the cause of the symptoms.[8][9] Also, one of mutations (D367Y to be exact) slightly increases activity of enzyme, which reduces specifity for the aspartate’s tRNA, and enzyme mischarges other amino acid’s tRNA with aspartate. Incorrectly charged tRNA causes accumulation of misfolded proteins, which is harmful for the cell.[9]
Because of the rarity of HBSL, exact prognosis is unknown, although if HBSL begins early, then prognosis would be worse.[4]
History
HBSL was first described by Taft and colleagues in 2013.[3]
Culture
MacPac Foundation is a non-profit organisation which is dedicated to raise awareness about HBSL, also raising funds for the scientist and affected families.[10]